• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mouse multivalent IgG(2a, b) antibody--ricin A-chain immunotoxins combined with homologous or heterologous interleukin 2 in the treatment of a murine malignant lymphoproliferation (EL4).

作者信息

Mota G, Marches R, Cialacu V, Roman V, Kozma E, Mărgineanu M, Dima S, Moraru I I

机构信息

Center of Immunology, Stefan Nicolau Institute of Virology, Bucharest, Romania.

出版信息

Arch Immunol Ther Exp (Warsz). 1996;44(2-3):131-6.

PMID:8915518
Abstract

Two immunotoxins containing ricin A-chain, staphylococcal protein A and mouse anti-Thy 1.2 antibodies of IgG(2a,b) subclass, were prepared. The two multivalent immunotoxins of 750 and 370 kDa and molar ratio A-chain: IgG of 1:2, were used for the treatment of mice bearing ascitic EL4 lymphoma. The immunotoxin-treatment, performed intraperitoneally, was combined or not with homologous or heterologous interleukin 2. The antitumor effects expressed by increase of mice survival time (p < 0.001 as compared with nontreated animals) corresponded to a proportion of 88-90% lymphoma cell-kill by immunotoxin and 93-95% by combination treatment (immunotoxin + interleukin 2), as calculated from the relationship between the survival time of nontreated mice and the number of tumor cells inoculated.

摘要

相似文献

1
Mouse multivalent IgG(2a, b) antibody--ricin A-chain immunotoxins combined with homologous or heterologous interleukin 2 in the treatment of a murine malignant lymphoproliferation (EL4).
Arch Immunol Ther Exp (Warsz). 1996;44(2-3):131-6.
2
In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.BCL1肿瘤的体内治疗:免疫毒素价态及蓖麻毒素A链去糖基化的影响
Cancer Res. 1988 May 1;48(9):2626-31.
3
Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins.用抗Thy 1.2特异性免疫毒素治疗腹水型小鼠EL4白血病。
Neoplasma. 1990;37(5):573-8.
4
Interleukin 2 enhances the efficiency of immunotoxins in the treatment of mice with ascitic tumors.白细胞介素2可提高免疫毒素治疗腹水瘤小鼠的效率。
Neoplasma. 1991;38(6):633-8.
5
Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.Fab'和IgG抗CD22免疫毒素对严重联合免疫缺陷病小鼠体内播散性人B淋巴瘤的抗肿瘤活性:对结外部位肿瘤细胞的影响
Cancer Res. 1991 Nov 1;51(21):5876-80.
6
Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.腹腔内免疫毒素在人恶性间皮瘤裸鼠模型中的抗肿瘤活性。
Cancer Res. 1987 Aug 15;47(16):4266-70.
7
Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.脂质乳剂中的莫能菌素用于增强蓖麻毒素A链免疫毒素。
Cancer Res. 1991 Aug 15;51(16):4316-22.
8
Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.蓖麻毒素A链化学去糖基化对由蓖麻毒素A链和抗Thy 1.1抗体组成的免疫毒素体内命运及细胞毒性活性的影响。
Cancer Res. 1987 Feb 15;47(4):947-52.
9
Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.抗B4阻断型蓖麻毒素免疫毒素在四种不同的重症联合免疫缺陷(SCID)小鼠肿瘤模型中显示出治疗效果。
Cancer Res. 1993 Mar 15;53(6):1360-7.
10
Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.人B淋巴细胞白血病/淋巴瘤新的严重联合免疫缺陷(SCID)和裸鼠模型的建立以及用免疫毒素和单克隆抗体对肿瘤进行有效治疗:SCID和裸鼠模型在单克隆抗体抗肿瘤疗效方面的显著差异
Cancer Res. 1994 May 15;54(10):2688-94.